Astra Biotech GmbH is in the pre-launch phase of its newly developed test, based on microarray technology, for rapid simultaneous detection of 25 of the most common mutations causing cystic fibrosis ...

This initiative supports Astra Biotech’s aim of facilitating early diagnosis of individuals’ risk factors through innovative assays. In this way long-term effects of a disease can be minimised and ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

It wasn’t all that long ago that we cracked the human genome, and in just a few short years we became used to direct-to-consumer genetic sequencing companies, like Ancestry.com and 23&Me, which could ...

Healthcare integration and regulatory framework address privacy concerns, ensuring genetic data security. Whole genome sequencing, microarray genetic analysis, and targeted analysis provide valuable ...